Proxima Therapeutics Inc.

Spine M&A

A business development panel representing the emerging group of mid-sized device dealmakers that are actively looking for innovative technology from small companies discusses the current state of medt

Novel molecular tests promise a healthier future for women—and the diagnostic makers who invest in them. Mention "women's health" and you're likely to elicit either a yawn or a groan of protest. Not t

In this issue, we present another installment of our quarterly review of dealmaking—for January-March 2005. Our data comes from Windhover's Strategic Intelligence Systems , which covers deal activity